Washington Research Foundation v. Sanofi
2:15-cv-01143
Overview
Parties
Defendant
Sanofi-Synthelabo LLC Operating Company
Represented By
5 Attorneys ListedYARMUTH WILSDON PLLC
1420 5TH AVENUE, SUITE 1400
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
Sanofi Operating Company
Represented By
5 Attorneys ListedYARMUTH WILSDON PLLC
1420 5TH AVENUE, SUITE 1400
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
SANOFI, GLOBAL INTELLECTUAL PROPERTY DEPT.
675 KENDALL STREET, CAMBRIDGE, MA 02142
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
Sanofi-Aventis U.S. LLC Operating Company
Represented By
6 Attorneys ListedYARMUTH WILSDON PLLC
1420 5TH AVENUE, SUITE 1400
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
SANOFI, GLOBAL INTELLECTUAL PROPERTY DEPT.
675 KENDALL STREET, CAMBRIDGE, MA 02142
MAYER BROWN LLP (NY)
1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020
Plaintiff
Washington Research Foundation NPE (University / Research)
Represented By
4 Attorneys ListedBYRNES KELLER CROMWELL LLP
1000 SECOND AVENUE, 38TH FLOOR
Third Party Plaintiff
Genentech, Inc. Operating Company
Represented By
4 Attorneys ListedBYRNES KELLER CROMWELL LLP
1000 SECOND AVENUE, 38TH FLOOR
Court & Judges
Court
District Court, W.D. Washington (wawd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,919,651 A Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 23,791,381 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 76,414,585 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 17,300,888 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 28,477,488 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 34,991,889 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 70,882,891 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,941,993 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 19,853,594 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 38,366,895 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5919651
Expression of polypeptides in yeast
|
Filed: 1995-06-06
Issued: 1999-07-06
|
Expired (Term Ended)
Expires: 2015-06-06
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
36
Dispositive
27
Granted
6
Denied
0
Pending / Review
28
Motions by Category
Key Dispositive Motions & Rulings